Public annual accounts

MADOLEX BELGIUM financials

Name: MADOLEX BELGIUM financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for MADOLEX BELGIUM, with comparable measures and links to available source documents.

Company overview

Registry number

0472881829

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for MADOLEX BELGIUM

2025 versus 2024

Operating line: €5,429,849
EBITDA: €323,266
Total assets: €1,936,387
Equity: €248,089

EBITDA margin +6% · Equity ratio +12.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€5,429,849	€323,266	€1,936,387	€248,089	-
202431 Dec 2024	€4,924,824	€393,163	€1,810,549	€286,211	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report